Document is current
Any future updates will be listed below
-
Authors
Virone, Alexandre https://orcid.org/0000-0003-2955-8449
Bastard, Jean-Philippe
Fellahi, Soraya
Capeau, Jacqueline
Rouanet, Stéphanie
Sibilia, Jean
Ravaud, Philippe
Berenbaum, Francis
Gottenberg, Jacques-Eric
Sellam, Jérémie
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01000441 at ClinicalTrials.govnct01000441 at ClinicalTrials.govDocuments that mention this clinical trial
Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
https://doi.org/10.1136/rmdopen-2019-000897
nct01331837 at ClinicalTrials.govDocuments that mention this clinical trial
Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
https://doi.org/10.1136/rmdopen-2019-000897
Documents that mention this clinical trial
Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
https://doi.org/10.1136/rmdopen-2019-000897
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
https://doi.org/10.1016/s0140-6736(12)60110-x
